International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3 , Pages 889-895 , 1 March 2010

Differential Radiosensitizing Effect of Valproic Acid in Differentiation Versus Self-Renewal Promoting Culture Conditions

Presented, in part, at the 2007 International Congress for Radiation Research, San Francisco, CA.

  • Bisrat G. Debeb, D.V.M., Ph.D.

      Affiliations

    • Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • Debeb BG and Xu W are equal contributors.
    • ,
  • Wei Xu, Ph.D.

      Affiliations

    • Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • Debeb BG and Xu W are equal contributors.
    • ,
  • Henry Mok, M.D., Ph.D.

      Affiliations

    • Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Li Li, B.S.

      Affiliations

    • Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Fredika Robertson, Ph.D.

      Affiliations

    • Division of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Naoto T. Ueno, M.D., Ph.D.

      Affiliations

    • Division of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Jim Reuben, Ph.D.

      Affiliations

    • Division of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Anthony Lucci, M.D.

      Affiliations

    • Division of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Massimo Cristofanilli, M.D.

      Affiliations

    • Division of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • ,
  • Wendy A. Woodward, M.D., Ph.D.

      Affiliations

    • Division of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX
    • Corresponding Author InformationReprint requests to: Wendy A. Woodward, M.D., Ph.D., Division of Radiation Oncology, University of M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 1202, Houston, TX 77030. Tel: (713) 563-8481; Fax: (713) 563-6940

Received 21 May 2009 ,Revised 22 September 2009 ,Accepted 25 September 2009.

References 

  1. Woodward WA, Chen MS, Behbod F, et al. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA. 2007;104:618–623
  2. Phillips TM, McBride WH, Pajonk F. The response of CD24(−/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006;98:1777–1785
  3. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458:780–783
  4. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–760
  5. Chiou SH, Kao CL, Chen YW, et al. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS ONE. 2008;3:e2090
  6. Meunier H, Carraz G, Neunier Y, et al. [Pharmacodynamic properties of N-dipropylacetic acid.]. Therapie. 1963;18:435–438
  7. Friedmann I, Atmaca A, Chow KU, et al. Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer. J Chemother. 2006;18:415–420
  8. Thelen P, Schweyer S, Hemmerlein B, et al. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. Int J Oncol. 2004;24:25–31
  9. Olsen CM, Meussen-Elholm ET, Roste LS, et al. Antiepileptic drugs inhibit cell growth in the human breast cancer cell line MCF7. Mol Cell Endocrinol. 2004;213:173–179
  10. Gottlicher M, Minucci S, Zhu P, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20:6969–6978
  11. Phiel CJ, Zhang F, Huang EY, et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001;276:36734–36741
  12. Gurvich N, Tsygankova OM, Meinkoth JL, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 2004;64:1079–1086
  13. Camphausen K, Cerna D, Scott T, et al. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int J Cancer. 2005;114:380–386
  14. Chinnaiyan P, Cerna D, Burgan WE, et al. Postradiation sensitization of the histone deacetylase inhibitor valproic acid. Clin Cancer Res. 2008;14:5410–5415
  15. Karagiannis TC, Kn H, El-Osta A. The epigenetic modifier, valproic acid, enhances radiation sensitivity. Epigenetics. 2006;1:131–137
  16. Bug G, Gul H, Schwarz K, et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res. 2005;65:2537–2541
  17. De Felice L, Tatarelli C, Mascolo MG, et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res. 2005;65:1505–1513
  18. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17:1253–1270
  19. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008;10:R25
  20. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–715
  21. Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138:645–659
  22. Braun KM, Niemann C, Jensen UB, et al. Manipulation of stem cell proliferation and lineage commitment: Visualisation of label-retaining cells in wholemounts of mouse epidermis. Development. 2003;130:5241–5255
  23. Dey D, Saxena M, Paranjape AN, et al. Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS ONE. 2009;4:e5329
  24. Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005;122:947–956
  25. Loh YH, Wu Q, Chew JL, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006;38:431–440
  26. Brown SL, Kolozsvary A, Liu J, et al. Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice. Radiat Res. 2008;169:474–478
  27. Huangfu D, Maehr R, Guo W, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 2008;26:795–797
  28. Botrugno OA, Santoro F, Minucci S. Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. Cancer Lett. 2009;280:134–144
  29. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: Can we see the forest for the trees?. Cell Mol Life Sci. 2007;64:2090–2103
  30. Beckers T, Burkhardt C, Wieland H, et al. Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer. 2007;121:1138–1148
  31. Munster PN, Troso-Sandoval T, Rosen N, et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res. 2001;61:8492–8497
  32. Zhou Q, Melkoumian ZK, Lucktong A, et al. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1. J Biol Chem. 2000;275:35256–35263
  33. Kuendgen A, Schmid M, Schlenk R, et al. The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia. Cancer. 2006;106:112–119
  34. Cimino G, Lo-Coco F, Fenu S, et al. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. Cancer Res. 2006;66:8903–8911
  35. Jain N, Rossi A, Garcia-Manero G. Epigenetic therapy of leukemia: An update. Int J Biochem Cell Biol. 2009;41:72–80
  36. Bug G, Schwarz K, Schoch C, et al. Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia. Haematologica. 2007;92:542–545
  37. Fiskus W, Pranpat M, Balasis M, et al. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Mol Cancer Ther. 2006;5:3096–3104
  38. Woodward WA, Bristow RG. Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology). Semin Radiat Oncol. 2009;19:87–95
  39. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008;8:545–554
  40. Baumann M, Krause M, Thames H, et al. Cancer stem cells and radiotherapy. Int J Radiat Biol. 2009;85:391–402
  41. Cordes N, Seidler J, Durzok R, et al. Beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene. 2006;25:1378–1390
  42. Sandfort V, Koch U, Cordes N. Cell adhesion-mediated radioresistance revisited. Int J Radiat Biol. 2007;83:727–732
  43. Olive PL, Durand RE. Drug and radiation resistance in spheroids: Cell contact and kinetics. Cancer Metastasis Rev. 1994;13:121–138

 Supported by the National Institutes of Health Grant R01CA138239-01; the State of Texas Grant for Rare and Aggressive Cancers; the American Airlines Komen Foundation Promise Grant KGO81287; the University of Texas M.D. Anderson Cancer Center Institutional Research Grant; and the University of Texas Health Sciences Center Grant KL2 RR024149.

 Conflict of interest: none.

PII: S0360-3016(09)03331-8

doi: 10.1016/j.ijrobp.2009.09.052

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3 , Pages 889-895 , 1 March 2010

Article Tools

* Image Usage & Resolution